| |
|
|
|
-, The Renaissance Washington, DC Hotel * Washington, DC
November 11-12, 2004
IBC’s 8th International Well Characterized Biological Conference serves as a leading resource for biotherapeutics industry scientists seeking updates on the latest analytical technologies for the characterization of biologics, and evolving regulatory policies. Presentations and case studies will provide you with blueprints for the successful integration of techniques that will improve your bottom line. Register for one – attend both! IBC’s 8th Conference on Well Characterized Biological is co-located with IBC’s 3rd Annual Post-Translational Modifications. This creates a rare opportunity for you to share perspectives and strategies with hundreds of leaders in the industry through track hopping, shared sessions, and interactive panel discussion, luncheons and cocktail reception. Program updates and registration information is available online at www.IBCLifeSciences.com/wcb; or, call IBC at +1 508-616-5550 x1004.
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
Keynote Address:
"FDA Perspectives on Specifications for Monoclonal Antibodies"
- Steven Kozlowski, Ph.D., Acting Director, Division of Monoclonal Antibodies, Office of Pharmaceutical Sciences, CDER, FDA
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
Online: www.IBCLifeSciences.com/wcb
Phone: (508) 616-5550 x1004
Fax: (508) 616-5522
E-mail: reg@ibcusa.com
|
|
|
E-mail:
|
|
reg@ibcusa.com
|
|
|
|
|
|
|
|
|